Latest Breaking News On - Yves levy - Page 1 : comparemela.com

LinKinVax Introduces its Scientific Advisory Board with the Appointment of Three Leading Experts in Immunology and Epidemiology

Prof. Anna Giuliano, Moffit Cancer Center, Tampa, Florida, USA Prof. Sharon Lewin, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia Prof. Giuseppe Pantaleo

LinKinVax Welcomes Interim Results of the ANRS VRI06 Phase I Trial Evaluating a Novel HIV Vaccine Candidate

First vaccine to target dendritic cells, key activators of the immune system Novel delivery of the HIV envelope protein potentially critical to future vaccine strategies Safe and able

LinKinVax and Gustave Roussy Collaborate on a Phase I/IIa HPV.DCVax Clinical Trial for the Treatment of Patients with HPV-Positive Oropharyngeal Cancer

CD40HVac, a therapeutic vaccine candidate in immuno-oncology targeting dendritic cells LinKinVax, a clinical-stage biotechnology company specialized in innovative protein-based vaccines, and Gustave

LinKinVax Raises €7.3M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

LinKinVax Just Completed a New Round of Financing, Initiated in 2022, for a Total of €7,3 M